Sanofi Statistics
Total Valuation
Sanofi has a market cap or net worth of $128.27 billion. The enterprise value is $146.22 billion.
Important Dates
The next confirmed earnings date is Thursday, January 30, 2025, before market open.
| Earnings Date | Jan 30, 2025 |
| Ex-Dividend Date | May 9, 2024 |
Share Statistics
Sanofi has 1.25 billion shares outstanding. The number of shares has decreased by -0.05% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.25B |
| Shares Change (YoY) | -0.05% |
| Shares Change (QoQ) | -0.46% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.10B |
Valuation Ratios
The trailing PE ratio is 25.52 and the forward PE ratio is 12.31.
| PE Ratio | 25.52 |
| Forward PE | 12.31 |
| PS Ratio | n/a |
| Forward PS | 2.69 |
| PB Ratio | n/a |
| P/TBV Ratio | 25.63 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 29.10 |
| EV / Sales | 2.71 |
| EV / EBITDA | 10.49 |
| EV / EBIT | 14.63 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.33 |
| Debt / EBITDA | 1.86 |
| Debt / FCF | n/a |
| Interest Coverage | 12.99 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | 5.88% |
| Revenue Per Employee | $627,636 |
| Profits Per Employee | $58,378 |
| Employee Count | 86,088 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Sanofi has paid $1.68 billion in taxes.
| Income Tax | 1.68B |
| Effective Tax Rate | 24.91% |
Stock Price Statistics
The stock price has decreased by -1.59% in the last 52 weeks. The beta is 0.45, so Sanofi's price volatility has been lower than the market average.
| Beta (5Y) | 0.45 |
| 52-Week Price Change | -1.59% |
| 50-Day Moving Average | 48.71 |
| 200-Day Moving Average | 50.97 |
| Relative Strength Index (RSI) | 63.19 |
| Average Volume (20 Days) | 2,287,449 |
Short Selling Information
| Short Interest | 4.21M |
| Short Previous Month | 3.74M |
| Short % of Shares Out | 0.34% |
| Short % of Float | 0.38% |
| Short Ratio (days to cover) | 1.76 |
Income Statement
In the last 12 months, Sanofi had revenue of $54.03 billion and earned $5.03 billion in profits. Earnings per share was $4.00.
| Revenue | 54.03B |
| Gross Profit | 37.34B |
| Operating Income | 10.00B |
| Pretax Income | 6.07B |
| Net Income | 5.03B |
| EBITDA | 13.94B |
| EBIT | 10.00B |
| Earnings Per Share (EPS) | $4.00 |
Full Income StatementBalance Sheet
The company has $7.58 billion in cash and $26.49 billion in debt, giving a net cash position of -$18.91 billion or -$15.09 per share.
| Cash & Cash Equivalents | 7.58B |
| Total Debt | 26.49B |
| Net Cash | -18.91B |
| Net Cash Per Share | -$15.09 |
| Equity (Book Value) | 81.42B |
| Book Value Per Share | 64.80 |
| Working Capital | n/a |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 69.12%, with operating and profit margins of 18.50% and 9.30%.
| Gross Margin | 69.12% |
| Operating Margin | 18.50% |
| Pretax Margin | 12.50% |
| Profit Margin | 9.30% |
| EBITDA Margin | 25.81% |
| EBIT Margin | 18.50% |
| FCF Margin | n/a |